Aprea Therapeutics CEO Christian Schade's 2022 pay falls 58% to $1.4M
Aprea Therapeutics reports 2022 executive compensation
By ExecPay News
Published: July 11, 2023
Aprea Therapeutics reported fiscal year 2022 executive compensation information on July 11, 2023.
In 2022, five executives at Aprea Therapeutics received on average a compensation package of $907K, a 52% decrease compared to previous year.
Average pay of disclosed executives at Aprea Therapeutics
Christian S. Schade, Chief Executive Officer, received $1.4M in total, which decreased by 58% compared to 2021. 42% of Schade's compensation, or $582K, was in option awards. Schade also received $282K in non-equity incentive plan, $328K in salary, as well as $182K in stock awards.
Scott M. Coiante, Chief Financial Officer, received a compensation package of $1M, which decreased by 41% compared to previous year. 39% of the compensation package, or $400K, was in salary.
Eyal C. Attar, Chief Medical Officer, earned $775K in 2022, a 59% decrease compared to previous year.
Oren Gilad, Chief Executive Officer, received $753K in 2022.
Gregory A. Korbel, Chief Operating Officer, earned $601K in 2022, a 10% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on July 11, 2023.